Abstract
PCBs are contaminants in the air of older buildings and cities, which raises the concern of inhalation exposure. No reliable biomarker of such exposure is available. We exposed rats to air containing 2 mg/m3 PCB3 via nose-only inhalation for 2 h, collected urine, and analyzed it by LC/MS. Each rat inhaled an estimated dose of 35 μg PCB3, and excreted 27±2 % of it as sulfates within 24 h. Peak excretion occurred within 6 h. PCB sulfates were stable in urine for at least three days at room temperature without chemical preservatives. These data support the use of PCB sulfate conjugates as suitable urinary biomarkers of PCB3 and other airborne PCBs.
Keywords: PCB, biomarker, sulfate conjugate
Polychlorinated biphenyls (PCBs) are ubiquitous persistent organic pollutants. PCBs have been identified in high levels inside buildings constructed or remodeled before 1977. The US EPA reported PCBs in several older public school buildings in New York City in 2012.1 The primary sources of PCBs in the US schools were electric ballasts and caulks. However, surfaces within the buildings and surroundings also absorbed and emitted PCBs as secondary sources. Elevated air concentrations have also been reported in cities like Chicago.2 One of the sources of air contamination across Chicago is the transfer of PCBs from the sediments of Lake Michigan to water and then to air.3 Some lower chlorinated PCBs, such as PCB11, may be inadvertently generated during the manufacturing of commercial paints and pigments.4 Vaporization of PCBs may arise from obsolete electrical transformers, aged electronics, and appliances. Airborne PCBs may also be a problem in places where E-waste recycling is carried out.5
Inhalation is an efficient route of PCBs uptake. Hu et al. conducted inhalation exposures to Aroclor 1242, a representative Chicago air mixture, and PCB11.6-8 These studies demonstrated that airborne PCBs are quickly absorbed and distributed to tissues from the lung. PCBs are eliminated within minutes to hours after exposure from rat liver, lung, brain and serum. Their rates of elimination differ by the nature of target organ as well as the substitution pattern of congeners. The US EPA has estimated that inhalation may contribute over seventy percent of exposures in the children attending contaminated schools.1
A reliable biological marker of effect of PCB exposure is not available because toxicities occur through various mechanisms associated with complex adverse effects, such as initiation of carcinogenesis,9 and endocrine disruption.10,11 The International Agency for Research on Cancer (IARC) has upgraded PCBs to Group 1 carcinogens.12 Therefore, accurate assessment of recent exposure of the occupants of contaminated buildings is a pressing public health issue.
Biomonitoring of PCB exposure is presently based on serum analysis of PCBs and, in research settings, OH-PCBs.13 There are limitations to this approach especially given the short half-lives of lower chlorinated PCBs. Only higher chlorinated OH-PCBs are selectively retained in the serum.14 Hydroxylated metabolites are not the final biotransformation products. We previously reported the oxidation and conjugation products of PCB3 in urine following a single i.p. administration in rats, and showed that sulfation is a major metabolism pathway for PCB3.15 In this study, we investigated if sulfate conjugates can serve as urinary biomarkers of inhalation exposure to air-borne PCB3 in rats. We chose PCB3 because it has a higher capacity of volatilization, is bioactivated to genotoxic metabolites, and is a major component in indoor air.16
The nose-only inhalation exposure was carried out as previously described.6 Three female Sprague Dawley rats (190-225 g) were exposed to PCB3 vapor for 2 h and transferred immediately thereafter to metabolism cages. Urine was collected every 6 h for up to 24 h, and stored at −20°C until analysis. Three control animals were exposed to laboratory air in a second nose-only system in an adjacent room. The vapor of PCB3 was generated from a round bottom glass flask containing 300 g glass beads, 4.75 mm diameter, coated with 2 g of the study material held in a 25°C water bath. A cartridge filled with 10 g polymeric resin (XAD, Supelco) was attached to the outlet of the exposure system to capture PCB3. Concentration of PCB3 in air was determined by Cair = PCB3 in XAD/(Flow rate* Time).6 We generated an atmosphere containing 2.0 mg/m3 of vapor phase PCB3 at an average flow rate of 10.8 L/min. In our trial experiments without animals, we achieved an air concentration of 3.3±1.7 mg/m3 PCB3 (n=7). The inhalation exposure dose was estimated by Dose/Rat=f*V*Cair*α*T.6 Assuming breathing frequency (f) in female rats of 94 breaths/min, vital volume (V) of 1.5 mL/breath, Cair of 2 mg/m3, and uptake through inhalation (α) of 100 %, each animal was estimated to have inhaled 35 μg PCB3.This is approximately one thousand times lower than i.p. administration dose in our previous study.15 For a quick reference, PCB levels in contaminated school buildings in New York are 500±154 ng/m3 and in Chicago air 75-5500 pg/m3.1,2 The Occupational Safety and Health Administration stipulates that workers not be exposed to 1 mg/m3 by inhalation over a period of 40 working hour week.
We have previously described a simultaneous extraction method for hydroxylated and conjugated metabolites of PCB3 from urine and serum.15 Here we modified the method for selective extraction of PCB sulfate, and briefly describe the changes. Urine (1 mL) was acidified with 40μL glacial acetic acid, and processed as previously described for serum. The acetonitrile (ACN) extract was reconstituted in 1 mL sodium acetate (SA) buffer (25 mM, pH 4.0), and applied to 1 cc capacity Oasis® WAX SPE cartridge, pre-conditioned with 1 mL methanol (MeOH) and 1 mL water. The column was sequentially washed with 1 mL SA buffer, 1 mL 100% MeOH, and 1 mL of 2% NH4OH (8M) in H2O:MeOH (50:50, v/v). Elution of the sulfate conjugates was accomplished with 1 ml of 2% NH4OH in MeOH: ACN (20:80, v/v). Finally, the solvent was evaporated, and the extract was reconstituted in 200μL MeOH:H2O (20:80, v/v).The ultraclean sample (5μL) was injected into LC/MS (Acquity TQD, Waters). Chromatography was performed on a BEH C18 column (2.1 × 10 mm, 1.7 μm) at 35°C. Mobile phases were 5 mM ammonium acetate (A), and 100% acetonitrile (B). Isocratic elution was achieved with 30% B at flow rate of 300μL/min. MS conditions were same as before,15 except the data were acquired in multiple reaction monitoring (MRM) of m/z 283 to 203, and 285 to 205. Quality control samples consisting of urine and solvent blanks, and spiked urine were simultaneously analyzed. The LOQ, as determined from the calibration standards,15 were 5, 2, and 8 ng/mL for 3PCB3, 3′PCB3, and 4′PCB3 sulfates. The concentrations in all cases were above the LOQ. The recoveries in the spiked samples were above 90% (Supporting figure S1).
Four different sulfate conjugates of PCB3 were identified. Three conjugates derived from mono-OH-PCB3 were confirmed by standards (Figure 1A). 3PCB3 sulfate and 2′PCB3 sulfate standards co-eluted as the first peak. We assigned this peak as 3PCB3 sulfate based on literature evidence.17 In single reaction monitoring (SRM) of m/z 299, we detected an intense signal for a sulfate conjugate of PCB3 derived from di-OH-PCB3 (Figure 1B), and this was confirmed by the pattern of fragmented daughter ions in MS/MS analysis (Figure 1C). We also detected metabolites that could be attributed to PCB3 mercapturate (m/z 348) as a good signal, and PCB3-glucuronide (m/z 379) as minor metabolites (data not shown). Figure 2 shows the cumulative excretion of different forms of sulfates over 24 h. The rate of excretion (the difference of cumulative excretion over time, as indicated by the slope of line between two time points), indicates that sulfates were formed rapidly until 12 h and decreased afterwards. Higher slope for 2-6 h indicates that peak excretion of sulfates occurred within this time. A strong signal for sulfates was already seen in the pooled droplets of urine droplets collected from nose-only inhalation system after 2 h. This early excretion suggests rapid absorption and metabolism of PCB3 after inhalation. Approximately 27±2% of the dose was excreted as 3PCB3 sulfate, 3′PCB3 sulfate, and 4′PCB3 sulfate within 24 h.
Figure 1. LC/MS chromatograms of urine after 6 h exposure showing the presence of several PCB3 sulfate conjugates.
(A) MRM chromatogram of m/z 383 to 203 showing conjugates of mono-OH-PCB3. (B) SIR chromatogram of m/z 299 and 283 showing relative peak height of di-OH-PCB3. (C) Mass spectrum of MS/MS analysis of m/z 299, showing relative abundances of daughter ions.
Figure 2. Time-course excretion of sulfates in urine.
Sulfate conjugates were rapidly excreted in urine within 12 h. Approximately 27±2 % dose was recovered as sulfate conjugates from 13±2 mL urine within 24 h. Values are mean of cumulative excretion at each time point±SD, n=3.
These results are consistent with our previous study in male rats after i.p. exposure, except in this study we found a of higher fraction of the dose excreted as sulfates.15 Although sulfotransferases (SULTs) and UDP glucuronosyl-transferases (UGTs) both utilize phenols as substrates, there are complex relationships that govern the rates of sulfation and glucuronidation with various individual molecules. It is generally considered that glucuronidation predominates sulfation at higher substrate concentrations, but we did not find a great deal of PCB3 glucuronides, even when the exposure dose was one thousand times higher than this study.15 OH-PCBs with chlorine atom substitutions in the meta- and para-positions have been shown to be less favorable as substrates for glucuronidation.18 Quantitative structure activity relationships for glucuronidation of OH-PCBs indicate that there are multiple physicochemical parameters involved in the interaction of these molecules with UGTs, and both hydrophobic and electronic characteristics were identified as major contributors.19 Several studies have described an inhibitory effect of OH-PCBs on SULTs, however, some of the most potent inhibitors of the sulfation reaction studied were actually alternative substrates for the enzyme.10,20-22 Rat SULT1A1 is a major isoform that efficiently catalyzes many lower chlorinated OH-PCBs.21 OH-PCB3s and OH-PCB11 are good substrates for human SULT1A1.11 This suggests that PCB sulfates may be similarly formed in humans.
Along with sensitivity and specificity, stability is an essential characteristic of a useful biomarker. We determined the stability of 11 different sulfate conjugates of typical airborne PCBs in human urine at different storage conditions for six weeks. Approximately 90% of all tested sulfates were recovered from storage at room temperature without aid of chemical preservatives after three days (Supporting information).
In conclusion, we showed that a significant amount of PCB3 was excreted as sulfate conjugates in urine after inhalation exposure. We described a straightforward procedure for storage, processing, and determination of PCB sulfates in urine. This study may be directly applied to biomonitoring of PCB3 exposure in the occupants of contaminated buildings.
Supplementary Material
ACKNOWLEDGMENT
We thank Drs. Xueshu Li, and Xianran He for the synthesis of authentic standards used in these studies, and members of our laboratory for their help with the animal studies.
Funding Sources
This study was supported by funding from NIH (ES013661 and ES005605). K.D. gratefully acknowledges support from the Iowa Superfund Research Program Training Core.
ABBREVIATIONS
- OH-PCBs
hydroxylated polychlorinated biphenyls
- SULT
sulfotransferase
- UGT
UDP glucuronosyltransferase
- EPA
Environmental Protection Agency
- LOQ
limit of quantification
- SPE
solid phase extraction
- SA
sodium acetate
- MeOH
methanol
- ACN
acetonitrile
Footnotes
Supporting Information Available. Stability of lower chlorinated PCB sulfates in human urine. This information available free of charge via the Internet at http://pubs.acs.org/.
These studies form a portion of the dissertation research of K.D. The opinions expressed are solely those of the authors and do not reflect an official policy of the granting agency. The authors declare no competing financial interest.
REFERENCES
- (1).Kent T, Xue J, Williams R, Jones P, Whitaker D. http://www.epa.gov/pcbsincaulk/pdf/pcb_EPA600R12051_final.pdf. [Google Scholar]
- (2).Hu D, Lehmler HJ, Martinez A, Wang K, Hornbuckle KC. Atmos. Environ. 2010;44:1550–1557. doi: 10.1016/j.atmosenv.2010.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (3).Martinez A, Wang K, Hornbuckle KC. Environ. Sci. Technol. 2010;44:2803–2808. doi: 10.1021/es902911a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (4).Hu D, Martinez A, Hornbuckle KC. Environ. Sci. Technol. 2008;42:7873–7877. doi: 10.1021/es801823r. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (5).Tue NM, Takahashi S, Suzuki G, Isobe T, Viet PH, Kobara Y, Seike N, Zhang G, Sudaryanto A, Tanabe S. Environ. Int. 2013;51:160–167. doi: 10.1016/j.envint.2012.11.006. [DOI] [PubMed] [Google Scholar]
- (6).Hu X, Adamcakova-Dodd A, Lehmler HJ, Hu D, Kania-Korwel I, Hornbuckle KC, Thorne PS. Environ. Sci. Technol. 2010;44:6893–6900. doi: 10.1021/es101274b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (7).Hu X, Adamcakova-Dodd A, Lehmler HJ, Hu D, Hornbuckle K, Thorne PS. Environ. Sci. Technol. 2012;46:9653–9662. doi: 10.1021/es301129h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (8).Hu X, Lehmler HJ, Adamcakova-Dodd A, Thorne PS. Environ. Sci. Technol. 2013;47:4743–4751. doi: 10.1021/es3049114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (9).Ludewig G, Robertson LW. Cancer Lett. 2013;334:46–55. doi: 10.1016/j.canlet.2012.11.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (10).Kester MH, Bulduk S, Tibboel D, Meinl W, Glatt H, Falany CN, Coughtrie MW, Bergman A, Safe SH, Kuiper GG, Schuur AG, Brouwer A, Visser TJ. Endocrinology. 2000;141:1897–1900. doi: 10.1210/endo.141.5.7530. [DOI] [PubMed] [Google Scholar]
- (11).Grimm FA, Lehmler HJ, He X, Robertson LW, Duffel MW. Environ. Health Perspect. 2013 doi: 10.1289/ehp.1206198. doi:10.1289/ehp.1206198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (12).Lauby-Secretan B, Loomis D, Grosse Y, Ghissassi FE, Bouvard V, Benbrahim-Tallaa L, Guha N, Baan R, Mattock H, Straif K. Lancet Oncol. 2013;14:287–288. [Google Scholar]
- (13).Marek RF, Thorne PS, Wang K, Dewall J, Hornbuckle KC. Environ. Sci. Technol. 2013;47:3353–3361. doi: 10.1021/es304455k. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (14).Bergman A, Klasson-Wehler E, Kuroki H. Environ. Health Perspect. 1994;102:464–469. doi: 10.1289/ehp.94102464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (15).Dhakal K, He X, Lehmler HJ, Teesch LM, Duffel MW, Robertson LW. Chem. Res. Toxicol. 2012;25:2796–2804. doi: 10.1021/tx300416v. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (16).Ludewig G, Lehmann L, Esch H, Robertson LW. Environ. Toxicol. Pharmacol. 2008;25:241, 246. doi: 10.1016/j.etap.2007.10.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (17).McLean MR, Bauer U, Amaro AR, Robertson LW. Chem. Res. Toxicol. 1996;9:158–164. doi: 10.1021/tx950083a. [DOI] [PubMed] [Google Scholar]
- (18).Tampal N, Lehmler HJ, Espandiari P, Mahnberg T, Robertson LW. Chem. Res. Toxicol. 2002;15:1259–1266. doi: 10.1021/tx0200212. [DOI] [PubMed] [Google Scholar]
- (19).Wang D. Arch. Toxicol. 2005;79:554–560. doi: 10.1007/s00204-005-0671-7. [DOI] [PubMed] [Google Scholar]
- (20).van den Hurk P, Kubiczak GA, Lehmler HJ, James MO. Environ. Health Perspect. 2002;110:343–348. doi: 10.1289/ehp.02110343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (21).Ekuase EJ, Liu Y, Lehmler HJ, Robertson LW, Duffel MW. Chem. Res. Toxicol. 2011;24:1720–1728. doi: 10.1021/tx200260h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (22).Liu Y, Smart JT, Song Y, Lehmler HJ, Robertson LW, Duffel MW. Drug Metab. Dispos. 2009;37:1065–1072. doi: 10.1124/dmd.108.026021. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


